J. William Freytag
Director/Board Member at BiOptix Diagnostics, Inc.
Profile
J.
William Freytag is currently a Director at BaroFold, Inc. and BiOptix Diagnostics, Inc. He was previously the Chairman, President & CEO of Gilead Colorado, Inc. from 1998 to 2006.
He also served as Chairman of Immunicon Corp.
from 1998 to 2008.
Additionally, he was the President-Research & Development at Roche Diagnostics Corp.
from 1990 to 1994.
Freytag holds an undergraduate degree from Purdue University and a doctorate from the University of Kansas.
J. William Freytag active positions
| Companies | Position | Start |
|---|---|---|
BiOptix Diagnostics, Inc.
 BiOptix Diagnostics, Inc. Electronic Equipment/InstrumentsElectronic Technology BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO. | Director/Board Member | - |
BaroFold, Inc.
 BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Director/Board Member | - |
Former positions of J. William Freytag
| Companies | Position | End |
|---|---|---|
| GLOBEIMMUNE, INC. | Chairman | - |
| ARCA BIOPHARMA, INC. | Director/Board Member | 2011-03-02 |
ARCA biopharma, Inc. /Old/
 ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Director/Board Member | 2009-01-26 |
| IMMUNICON CORP. | Chairman | 2008-05-31 |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada. | Chief Executive Officer | 2007-12-31 |
Training of J. William Freytag
| Purdue University | Undergraduate Degree |
| University of Kansas | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ARCA BIOPHARMA, INC. | Health Technology |
| GLOBEIMMUNE, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Private companies | 11 |
|---|---|
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Health Technology |
Immunicon Corp.
 Immunicon Corp. Medical SpecialtiesHealth Technology Immunicon Corp. develops, manufactures, markets and sells proprietary cell-based diagnostic and research products and services. It provides services to pharmaceutical and biotechnology companies to develop new therapeutic agents, which focuses on cancer disease management. Immunicon's products and technology platforms have application in cancer research and in other fields of medicine, such as cardiovascular and infectious disease. The company was founded in 1983 and is headquartered in Huntingdon Valley, PA. | Health Technology |
BioStratum, Inc.
 BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada. | Health Technology |
BiOptix Diagnostics, Inc.
BiOptix Diagnostics, Inc. Electronic Equipment/InstrumentsElectronic Technology BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO. | Electronic Technology |
Somatogen, Inc.
 Somatogen, Inc. BiotechnologyHealth Technology Somatogen, Inc. develops specialty oxygen therapeutics. It is engaged in the research, clinical development and commercialization of genetically engineered recombinant human hemoglobin-based products. The company is located in Boulder, CO. | Health Technology |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Health Technology |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
| Nuvelo, Inc. | Health Technology |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Health Technology |
BaroFold, Inc.
BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Health Technology |
- Stock Market
- Insiders
- J. William Freytag
